Inovio Pharmaceuticals Inc
(NAS:INO)
$
1.96
0.14 (7.69%)
Market Cap: 70.76 Mil
Enterprise Value: -1.60 Mil
PE Ratio: 0
PB Ratio: 0.69
GF Score: 63/100 Inovio Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 18, 2021 / 01:45PM GMT
Gregory James Renza
RBC Capital Markets, Research Division - Analyst
And welcome back to the 2021 RBC Global Healthcare Conference. My name is Gregory Renza, one of the senior biotechnology equity research analysts here at RBC, and we're pleased to have INOVIO Pharmaceuticals. And joining us from INOVIO is President and Chief Executive Officer, Dr. Joseph Kim. And if you have any questions for Joseph, please feel free to enter those in the web portal below, and we will be happy to ask those on your behalf. So Joseph, thank you for joining us.
J. Joseph Kim
Inovio Pharmaceuticals, Inc. - CEO, President & Director
Well, great to be here. Thanks for inviting me.
Gregory James Renza;J. Joseph Kim
RBC Capital Markets, Research Division - Analyst;Inovio Pharmaceuticals, Inc. - CEO,
Thank you. So let's get right to it. And perhaps before we do dive right in, could you just provide us a brief overview of INOVIO's core technology as well as just a little color on the pipeline programs?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot